33Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry.
Apenteng PN., Murray ET., Hobbs FD., Kakkar AK., Fitzmaurice DA.
Evidence based atrial fibrillation (AF) management guidelines recommend oral anticoagulation (OAC) for patients with atrial fibrillation at moderate to high risk of stroke and without contraindications regardless of type of atrial fibrillation. The literature suggests a misconception about stroke risk in relation to type of AFresulting in a significant proportion of patients with paroxysmal AF not receiving prophylactic anticoagulation. It is unclear if this misconception persists in clinical practice. Using UK data from a global AF registry we investigated the use of antithrombotic therapy according to CHADS2score and type of AF.